Clinical Trial Update: Exisulind Versus Placebo After Surgical Removal of the Prostate [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial compared exisulind to placebo following surgical removal of the prostate to assess efficacy and safety in prostate cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Exisulind (exisulind)

Snippet

Sponsor: Mayo Clinic | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED